SCHEMBL2013731

SCHEMBL2013731

Cc1c(Cl)cc(CC=O)c(-c2cccc(F)c2)c1N

nearest known ligand 0.36

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.36
TAAR1 Q96RJ0 3/20 0.35
ADORA1 P30542 3/20 0.33
ADORA2A P29274 2/20 0.33
PTPN11 Q06124 2/20 0.32
DPP4 P27487 1/20 0.31
KDM4E B2RXH2 2/20 0.31
P2RX7 Q99572 1/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9952973 0.87 GRIN2D (0.31)
SCHEMBL9952150 0.85 AR (0.36) ARTAAR1PTPN11P2RX7PTGS2
SCHEMBL2017946 0.81 LMNA (0.37) ARMEN1MAPTKMT2APTGS2
SCHEMBL2015782 0.78 NT5E (0.36) TAAR1ADORA2AKDM4EMEN1MAPT
SCHEMBL3907818 0.77 AR (0.41) ARTAAR1PTGS2
SCHEMBL2013729 0.74 TRPM8 (0.38) TAAR1ADORA1ADORA2APTPN11KDM4E
SCHEMBL10279064 0.73 PIK3CD (0.41) TAAR1ADORA1ADORA2AKDM4EMEN1
SCHEMBL2015005 0.72 PIK3CD (0.44) KDM4EMEN1MAPTKMT2A
SCHEMBL2015518 0.72 ADORA1 (0.32) TAAR1ADORA1ADORA2APTPN11
SCHEMBL2017111 0.71 NLRP3 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655374-A1 N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS Incyte Corporation (US) 2013-10-30 EP disclosed
WO-2012087881-A1 N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2012-06-28 WO disclosed
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed